...
首页> 外文期刊>Biotechnology and Bioengineering >Coupling recombinase-mediated cassette exchange with somatic hypermutation for antibody affinity maturation in CHO cells
【24h】

Coupling recombinase-mediated cassette exchange with somatic hypermutation for antibody affinity maturation in CHO cells

机译:将重组酶介导的盒交换与体细胞超突变耦合以在CHO细胞中实现抗体亲和力成熟

获取原文
获取原文并翻译 | 示例

摘要

Heterologous expression of activation-induced cytidine deaminase (AID) can induce somatic hypermutation (SHM) for genes of interest in various cells, and several research groups (including ours) have successfully improved antibody affinity in mammalian or chicken cells using AID-induced SHM. These affinity maturation systems are time-consuming and inefficient. In this study, we developed an antibody affinity maturation platform in Chinese hamster ovary (CHO) cells by coupling recombinase-mediated cassette exchange (RMCE) with SHM. Stable CHO cell clones containing a single copy puromycin resistance gene (PuroR) expression cassette flanked by recombination target sequences (FRT and loxP) being able to highly express a gene of interest placed in the cassette were developed. The PuroR gene was replaced with an antibody gene by RMCE, and the antibody was displayed on the cell surface. Cells displaying antibodies on their membrane were transfected with the AID gene, and mutations of the antibody gene were accumulated by AID-mediated hypermutation during cell proliferation followed by flow cytometric cell sorting for cells bearing antibody mutants with improved affinity. Affinity improvements were detected after only one round of cell sorting and proliferation, mutant clones with 15-fold affinity improvement were isolated within five rounds of maturation (within 2 months). CHO cells are fast growing, stress-resistant and produce antibody with glycosylations suitable for therapy. Our antibody-evolution platform based on CHO cells makes antibody-affinity maturation more efficient and is especially convenient for therapeutic antibody affinity improvement. Biotechnol. Bioeng. 2016;113: 39-51. (c) 2015 Wiley Periodicals, Inc.
机译:激活诱导的胞苷脱氨酶(AID)的异源表达可以诱导各种细胞中目的基因的体细胞超突变(SHM),并且几个研究小组(包括我们的研究小组)已成功使用AID诱导的SHM改善了哺乳动物或鸡细胞中的抗体亲和力。这些亲和力成熟系统既费时又效率低下。在这项研究中,我们通过将重组酶介导的盒式交换(RMCE)与SHM偶联,在中国仓鼠卵巢(CHO)细胞中开发了抗体亲和力成熟平台。已开发出稳定的CHO细胞克隆,该克隆包含单拷贝的嘌呤霉素抗性基因(PuroR)表达盒,其侧翼是重组靶序列(FRT和loxP),能够高度表达置于盒中的目标基因。用RMCE将PuroR基因替换为抗体基因,并将该抗体展示在细胞表面。用AID基因转染在其膜上显示抗体的细胞,并在细胞增殖过程中通过AID介导的超突变积累抗体基因的突变,然后通过流式细胞术分选出具有改善的亲和力的抗体突变体的细胞。仅在一轮细胞分选和增殖后,亲和力得到改善,在五个回合的成熟期内(两个月内)分离出亲和力提高15倍的突变克隆。 CHO细胞快速生长,具有抗逆性,并产生具有适用于治疗的糖基化抗体。我们基于CHO细胞的抗体进化平台使抗体亲和力成熟更加有效,并且特别适合于治疗性抗体亲和力的提高。生物技术。生恩2016; 113:39-51。 (c)2015年威利期刊有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号